Oncoinvent ASA has completed a substantial share capital reduction, cutting its capital from NOK 223.9 million to NOK 1.1 million by lowering the nominal value of each share from NOK 50 to NOK 0.25, ...

Cancer treatment is rarely a completely linear journey, said Dr Jeyhan B. Dhabhar, medical oncologist, Head Neck Cancer ...

Speaking with his co-host Cherry Healey, Dr Amir - who is best recognised for his appearances on ITV, explained that the ...

A doctor has urged anyone experiencing a common symptom to seek medical help. Bloating that lasts three weeks or more should ...

A doctor has urged anyone experiencing a common symptom to seek medical attention. Bloating that persists for three weeks or ...

A GP has warned that anyone experiencing a particular symptom should not delay seeking medical attention. Persistent bloating ...

On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated ...

Women with endometriosis have an elevated risk of developing epithelial ovarian cancer, but, when they do develop it, they ...

Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality. Researchers at Rice University, in collaboration ...

Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step ...

Researchers developed a model to predict risk of TIPN in patients with early-stage cancer treated with a taxane regimen.

Rezatapopt granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of TP53 Y220C positive ovarian cancerNew ...